Eric Talbot (SVP) and Surya Pandruvada (VP) join MMA’s management team to help shape and deliver commercial ROI capabilities to pharmaceutical sales and marketing teams
New York, New York, June 25, 2015 – Marketing Management Analytics (MMA), a leader for the past 25 years in helping Fortune 500 companies leverage predictive analytics to plan, execute, forecast and optimize their commercial investments, today announced the addition of two senior executives to support its growth in the pharma sector.
Eric Talbot will join MMA as the Senior Vice President responsible for leading the growth and innovation in pharma. Eric brings with him over twenty-years of experience in analytics and linking them to problem-solving sales and marketing challenges of pharmaceutical companies.
Joining Eric is Surya Pandruvada who recently came over to MMA from Novartis.
“As the demand for ongoing value creation from our clients continues to grow, it is critical for us to continue to add seasoned executives who are capable of delivering and translating analytic results into forward-looking plans for marketing and sales operations decision makers, ” said Doug Brooks, EVP at MMA. “At the same time it is equally important we help our clients drive the necessary change management to fuel usage and adoption. Eric and Surya both bring a rich blend of deep analytics as well as pharma industry expertise that enables them to not only produce recommended results but equally importantly help teams understand, apply and leverage them to create greater returns from sales and marketing investments.”
Eric joins MMA with nearly two decades of international consulting experience. His proficiency spans healthcare (pharma, OTC, payer & provider), multicultural marketing, forecasting, response modeling, market assessment and segmentation). Most recently in his role as Vice President, Strategy and Insights at Univision Communication Inc. he led a consulting team focused on leveraging analytics within healthcare and pharmaceutical organizations in order to better understand and connect with Hispanic patients and consumers. Prior to Univision he was Senior Director of Strategic Consulting at Advantage Management Solutions and Director of Marketing Effectiveness at Verispan/SDI Health. Eric’s career in healthcare analytics began with IMS having held positions of increasing responsibility on both the data and consulting in numerous countries.
Surya joins MMA from Novartis Pharmaceuticals where he was Associate Director of Strategic Insights & Analytics, responsible for leading promotion mix and new commercial channel analytics for specialized brands. At Novartis Pharma he played a lead role in setting up appropriate KPIs for measuring HCP and consumer focused digital initiatives and developing the analytical plan for execution and evaluation of such strategies. Prior to Novartis, Surya played a leadership role at Merkle where he led the analytical engagement for one of Merkle’s largest accounts. His experience includes escalating roles in analytics at FedEx and National Grid.
MMA has been working with some of the largest global pharmaceutical companies to optimize their commercial investments in retail and specialty brands for more than 14 years. The company provides cross-functional decision makers with real-time and forward-looking insights that pinpoint incremental value by targeting optimal budgeting by portfolio and brand and maximizing the impact of commercial investments on sales, prescriptions and patients in both retail and specialty markets. “We are getting to the heart of important pharma investment and allocation decisions, ” said Brooks. “The results of our work help clients shape better investment decisions at the physician segment and district levels while helping optimize salesforce alignment and PDEs. This understanding enables our client partners to target and drive measureable improvements in the ROI of their salesforce and marketing investments.”